Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Kiniksa Pharmaceuticals International Plc shares valued at $368,466 were sold by Ragosa Mark on Mar 20 ’25. At $23.11 per share, Ragosa Mark sold 15,944 shares. The insider’s holdings dropped to 23,382 shares worth approximately $0.55 million following the completion of this transaction.
Also, Ragosa Mark sold 11,464 shares, netting a total of over 264,818 in proceeds. Following the sale of shares at $23.10 each, the insider now holds 23,382 shares.
Before that, Ragosa Mark had sold 8,879 shares from its account. In a trade valued at $205,105, the CHIEF FINANCIAL OFFICER traded Kiniksa Pharmaceuticals International Plc shares for $23.10 each. Upon closing the transaction, the insider’s holdings decreased to 8,879 shares, worth approximately $0.55 million.
As published in their initiating research note from Citigroup on March 13, 2025, Kiniksa Pharmaceuticals International Plc [KNSA] has been a Buy and the price target has been revised to $40. Analysts at Jefferies started covering the stock with ‘”a Buy”‘ outlook in a report released in mid September. As of May 03, 2024, Wells Fargo has initiated its “an Overweight” rating for KNSA. Earlier on June 29, 2020, BofA Securities resumed its rating. Their recommendation was “a Buy” for KNSA stock.
Analyzing KNSA Stock Performance
During the last five days, there has been a drop of approximately -1.89%. Over the course of the year, Kiniksa Pharmaceuticals International Plc shares have jumped approximately 18.10%. Shares of the company reached a 52-week high of $24.31 on 03/20/25 and a 52-week low of $17.82 on 01/13/25. A 50-day SMA is recorded $20.65, while a 200-day SMA reached $22.35.
Support And Resistance Levels for Kiniksa Pharmaceuticals International Plc (KNSA)
According to the 24-hour chart, there is a support level at 22.91, which, if violated, would cause prices to drop to 22.47. In the upper region, resistance lies at 23.61. The next price resistance is at 23.87. RSI (Relative Strength Index) is 63.18 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.37, which suggests the price will decrease in the coming days. Percent R is at 24.23%, indicating bullish price movement. Stochastics %K at holding indicates that the stock is to be held.
